- Home
- TNGX vs MYI Comparison
TNGX vs MYI Comparison
Compare TNGX & MYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MYI
- Stock Information
- Founded
- TNGX 2014
- MYI 1992
- Country
- TNGX United States
- MYI United States
- Employees
- TNGX N/A
- MYI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MYI Investment Bankers/Brokers/Service
- Sector
- TNGX Health Care
- MYI Finance
- Exchange
- TNGX Nasdaq
- MYI Nasdaq
- Market Cap
- TNGX 723.0M
- MYI 701.9M
- IPO Year
- TNGX N/A
- MYI N/A
- Fundamental
- Price
- TNGX $6.53
- MYI $10.37
- Analyst Decision
- TNGX Strong Buy
- MYI
- Analyst Count
- TNGX 5
- MYI 0
- Target Price
- TNGX $10.50
- MYI N/A
- AVG Volume (30 Days)
- TNGX 1.9M
- MYI 256.7K
- Earning Date
- TNGX 08-05-2025
- MYI 01-01-0001
- Dividend Yield
- TNGX N/A
- MYI 4.81%
- EPS Growth
- TNGX N/A
- MYI N/A
- EPS
- TNGX N/A
- MYI N/A
- Revenue
- TNGX $40,990,000.00
- MYI N/A
- Revenue This Year
- TNGX N/A
- MYI N/A
- Revenue Next Year
- TNGX N/A
- MYI N/A
- P/E Ratio
- TNGX N/A
- MYI N/A
- Revenue Growth
- TNGX 10.09
- MYI N/A
- 52 Week Low
- TNGX $1.03
- MYI $9.32
- 52 Week High
- TNGX $12.02
- MYI $11.70
- Technical
- Relative Strength Index (RSI)
- TNGX 60.33
- MYI 49.87
- Support Level
- TNGX $6.36
- MYI $10.22
- Resistance Level
- TNGX $7.11
- MYI $10.33
- Average True Range (ATR)
- TNGX 0.52
- MYI 0.08
- MACD
- TNGX -0.13
- MYI 0.01
- Stochastic Oscillator
- TNGX 53.15
- MYI 56.67
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About MYI Blackrock MuniYield Quality Fund III Inc
BLACKROCK MUNIYIELD QUALITY FUND III, INC. is a investment management company. Its investment objective is to provide shareholders with a high level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in various sectors such as Transportation; Utilities; Health; Education; Tobacco and others.